This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

IGF-1R Inhibitor OSI-906

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What IGF-1R Inhibitor OSI-906 Means

IGF-1R Inhibitor OSI-906, often called OSI-906, is a drug being studied in cancer research. It works by blocking a protein called insulin-like growth factor 1 receptor (IGF-1R). This protein is found in higher amounts on some cancer cells and helps them grow and survive. By blocking IGF-1R, OSI-906 may slow down or stop the growth of tumors and possibly cause cancer cells to die.

Why It Can Matter in Cancer Care

Some cancers rely on IGF-1R to grow and spread. Because of this, drugs like OSI-906 that block this protein are being tested to see if they can help treat these cancers. While OSI-906 is not yet a standard treatment, it represents a type of targeted therapy aimed at interfering with specific molecules that cancer cells need. This approach may offer new options for patients in the future.

What Patients Might See or Hear About OSI-906

Patients may come across the term OSI-906 or IGF-1R Inhibitor OSI-906 in various places such as medical reports, clinical trial information, or educational materials. It might appear as part of a treatment plan discussion or in test results. Because the drug is still being studied, seeing the name does not mean it is currently being used or recommended for treatment. It is important to ask your healthcare team what it means for your specific care.

Common Confusions and How to Understand the Term

OSI-906 may be listed under different but related names, so comparing wording in reports can help avoid confusion. The term itself is not a diagnosis or a treatment recommendation. It is a name for a drug under study. Patients should not assume that seeing this term means they will receive this drug or that it is proven effective for their cancer type.

Questions to Ask Your Care Team

If you see OSI-906 mentioned, consider asking your care team what role this drug might have in your care. Questions could include: Is this drug part of my treatment plan or a clinical trial? What does blocking IGF-1R mean for my cancer? Are there side effects or risks? How does this drug compare to other treatments?

Reading the Term in Context

Understanding OSI-906 requires seeing it in the context of your medical situation. It is best to discuss any mention of this drug with your healthcare providers to learn how it applies to you. This helps avoid misunderstanding or worry about unfamiliar terms.

Safety and Next Steps

This information is educational and does not decide what is safe or effective for any individual. If OSI-906 appears in your medical records or discussions, the safest next step is to ask your care team for clear explanations about what it means for your diagnosis, treatment options, or clinical trials. Your healthcare team can guide you on whether this drug is relevant to your care and what to expect.

Sources

Public source information used for this glossary entry includes: